Assessment and Treatment of Caffeine Dependence
Completed · Phase 1
Conditions studied: Self-identified Problematic Caffeine Use, DSM-IV Substance Dependence as Applied to Caffeine
In brief
Recent research has established that some individuals report that they are unable to cease caffeine use, despite feeling that caffeine is posing a health risk or causing significant impairment in their daily activities. Despite the high rates of unsuccessful efforts to cease or control caffeine use in the population, there has been little research on the parameters of successful caffeine reduction and no research on caffeine cessation. The goals of the study are as follows: 1. evaluate the applicability of DSM-IV dependence criteria for self-reported problematic caffeine use. 2. evaluate characteristics (e.g, co-morbid psychopathology) of individuals who report that they have had difficulty quitting caffeine use on their own and who are seeking treatment for caffeine use. 3. test the efficacy of a caffeine reduction treatment administered to individuals who would like to quit/reduce caffeine use, but have found it difficult to do so in the past.
Key facts
- Study ID
- NCT00338195
- Run by
- Johns Hopkins University
- People needed
- 94
- Starts
- 2001-05-01
- Expected to finish
- 2009-12-01
- Last updated by the study team
- 2013-03-07
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Consume >100mg caffeine per day
- 18-65 years old
- Medically healthy
- Self-reported problem with caffeine use.
You may not qualify if…
- Pregnancy
- Current dependence on alcohol or illicit drugs.
Where it is running
- Behavioral Biology Research Center, Johns Hopkins Bayview — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.